|
|
PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers
V. Vendrely
,
C. Lemanski
,
E. Le Prise
,
E. Maillard
,
X. Mirabel
et al.
ESTRO 36, May 2017, Vienne, Austria. , Radiotherapy and Oncology, 123 (Supplement 1), pp.S367 - S368, 2017, ESTRO 36, May 5-9, 2017, Vienna, Austria. ⟨10.1016/S0167-8140(17)31139-8⟩
Poster de conférence
hal-01685153v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study
Côme Lepage
,
J-M. Phelip
,
Astrid Lièvre
,
Karine Le Malicot
,
L Dahan
et al.
Article dans une revue
hal-03810530v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20
T. Aparicio
,
O. Bouché
,
E. Francois
,
E. Maillard
,
S. Kirscher
et al.
Communication dans un congrès
hal-01524852v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial
J-B. Bachet
,
O. Lucidarme
,
C.B. Levache
,
E. Maillard
,
J.L. Raoul
et al.
Communication dans un congrès
hal-01632415v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T. Aparicio
,
O. Bouché
,
J. Taieb
,
E. Maillard
,
S. Kirscher
et al.
Article dans une revue
hal-01699429v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer
T. Aparicio
,
O. Bouché
,
E. Francois
,
F. Retornaz
,
E. Barbier
et al.
Article dans une revue
hal-02012206v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial
J.B. Bachet
,
O. Lucidarme
,
C.B. Levache
,
E. Barbier
,
J.L. Raoul
et al.
Article dans une revue
hal-01960176v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort
T. Walter
,
T Tougeron
,
Emmanuel Baudin
,
K. Le Malicot
,
T. Lecomte
et al.
Article dans une revue
hal-01609152v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|